[go: up one dir, main page]

AR041690A1 - Derivados de piridoindolona substituidos en 3- por un grupo heterociclico su preparacion y su aplicacion en terapeutica - Google Patents

Derivados de piridoindolona substituidos en 3- por un grupo heterociclico su preparacion y su aplicacion en terapeutica

Info

Publication number
AR041690A1
AR041690A1 ARP030103841A ARP030103841A AR041690A1 AR 041690 A1 AR041690 A1 AR 041690A1 AR P030103841 A ARP030103841 A AR P030103841A AR P030103841 A ARP030103841 A AR P030103841A AR 041690 A1 AR041690 A1 AR 041690A1
Authority
AR
Argentina
Prior art keywords
group
indolyl
pyrazole
application
derivatives substituted
Prior art date
Application number
ARP030103841A
Other languages
English (en)
Inventor
Bernard Bourrie
Pierre Casellas
Jean Marie Derocq
Samir Jegham
Yvette Muneaux
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of AR041690A1 publication Critical patent/AR041690A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

La presente se refiere a derivados de piridoindolona substituidos en -3 por un grupo heterocíclico de fórmula general (1): en la cual: -R1 representa un átomo de hidrógeno o un grupo alquilo (C1-4); -R2 representa un átomo de hidrógeno o un grupo alquilo (C1-4); -R3 representa un tienilo mono o polisubstituido por un grupo metilo; o un radical heterocíclico, monocíclico o bicíclico elegido entre: un piridilo, un N-oxidopiridilo, un pirazol, un (N-fenil) pirazol, un (N-halogenofenil) pirazol, un furilo, un indolilo, un (N-bencil) indolilo, un (N-halogenobencil) indolilo, un benzotienilo, un benzofurilo, y dichos radicales son no substituidos o substituidos una o varias veces por un átomo de halógeno o un grupo metilo o metoxi; -R4 y R5 son idénticos o diferentes y cada uno representa independientemente un átomo de hidrógeno o de halógeno o un grupo hidroxilo, un hidroximetilo, alquilo (C1-4), trifluorometilo, alcoxi(C1-4), alcoxicarbonilo (C1-4), un ciano; Procedimiento de preparación y composiciones farmacéuticas y su aplicación en el tratamiento y prevención de las enfermedades causadas o exacerbados por células tumorales.
ARP030103841A 2002-10-23 2003-10-22 Derivados de piridoindolona substituidos en 3- por un grupo heterociclico su preparacion y su aplicacion en terapeutica AR041690A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0213270A FR2846330B1 (fr) 2002-10-23 2002-10-23 Derives de pyridoindolone substitues en -3 par groupe heterocyclique, leur preparation et leur application en therapeutique

Publications (1)

Publication Number Publication Date
AR041690A1 true AR041690A1 (es) 2005-05-26

Family

ID=32088226

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP030103841A AR041690A1 (es) 2002-10-23 2003-10-22 Derivados de piridoindolona substituidos en 3- por un grupo heterociclico su preparacion y su aplicacion en terapeutica

Country Status (13)

Country Link
EP (1) EP1556380B1 (es)
JP (1) JP4599164B2 (es)
AR (1) AR041690A1 (es)
AT (1) ATE323091T1 (es)
AU (1) AU2003292285A1 (es)
CY (1) CY1105158T1 (es)
DE (1) DE60304596T2 (es)
DK (1) DK1556380T3 (es)
ES (1) ES2263033T3 (es)
FR (1) FR2846330B1 (es)
PT (1) PT1556380E (es)
TW (1) TW200418853A (es)
WO (1) WO2004037821A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2823975B1 (fr) 2001-04-27 2003-05-30 Sanofi Synthelabo Nouvelle utilisation de pyridoindolone
FR2846329B1 (fr) 2002-10-23 2004-12-03 Sanofi Synthelabo Derives de pyridoindolone substitues en -3 par un phenyle, leur preparation et leur application en therapeutique
FR2869316B1 (fr) 2004-04-21 2006-06-02 Sanofi Synthelabo Derives de pyridoindolone substitues en -6, leur preparation et leur application en therapeutique.
FR2892416B1 (fr) 2005-10-20 2008-06-27 Sanofi Aventis Sa Derives de 6-heteroarylpyridoindolone, leur preparation et leur application en therapeutique
JP7214879B2 (ja) * 2019-02-01 2023-01-30 メッドシャイン ディスカバリー インコーポレイテッド c-Met阻害剤としてのピリミジニルを含むトリシクリル系化合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4263304A (en) * 1978-06-05 1981-04-21 Sumitomo Chemical Company, Limited 7 H-indolo[2,3-c]isoquinolines
FR2765581B1 (fr) * 1997-07-03 1999-08-06 Synthelabo Derives de 3-aryl-1,9-dihydro-2h-pyrido[2,3-b]indol-2-one, leur preparation et leur application en therapeutique
FR2765582B1 (fr) * 1997-07-03 1999-08-06 Synthelabo Derives de 3-alkyl-1,9-dihydro-2h-pyrido[2,3-b]indol-2-one leur preparation et leur application en therapeutique

Also Published As

Publication number Publication date
CY1105158T1 (el) 2010-03-03
EP1556380A1 (fr) 2005-07-27
ATE323091T1 (de) 2006-04-15
DK1556380T3 (da) 2006-08-14
FR2846330B1 (fr) 2004-12-03
ES2263033T3 (es) 2006-12-01
PT1556380E (pt) 2006-08-31
JP4599164B2 (ja) 2010-12-15
DE60304596D1 (de) 2006-05-24
TW200418853A (en) 2004-10-01
JP2006505577A (ja) 2006-02-16
WO2004037821A1 (fr) 2004-05-06
DE60304596T2 (de) 2007-05-10
AU2003292285A1 (en) 2004-05-13
FR2846330A1 (fr) 2004-04-30
EP1556380B1 (fr) 2006-04-12

Similar Documents

Publication Publication Date Title
EA200800555A1 (ru) Производные ксантина в качестве селективных агонистов hm74a
CY1114148T1 (el) Γεφυρωμενες δικυκλικες αρυλο- και γεφυρωμενες δικυκλικες etepoapyλo-υποκατεστημενες τριαζολες χρησιμες ως αναστολεις toy axl
WO2006078621A3 (en) 2-phenoxy-n- (1, 3 , 4-thiadizol-2-yl) pyridin-3-amine derivatives and related compounds as p2y1 receptor inhibitors for the treatment of thromboembolic disorders
NO20063599L (no) Ytterligere heterosykliske forbindelser og deres anvendelse som metabotrofiske glutamatreseptorantagonister
ATE370139T1 (de) Pyrazolopyridin derivate als tgf beta hemmstoffe zur behandlung von krebs
BR0309309A (pt) Antagonistas de receptor de trombina tricìclicos
NO20054082L (no) Pyrazol`1,5-A! 1,3,5! triazinderivater som kannabinoidreseptorligander
HUP0301431A2 (hu) 3-Indolil-4-fenil-1H-pirrol-2,5-dion-származékok, mint glikogén szintáz kináz-3béta inhibitorok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
BRPI0515488A (pt) derivados de heterocìclicos e seu uso como agentes terapêuticos
JO2764B1 (en) Indole derivatives or benzimidazole derivatives to modify the enzyme AKP kinase
BRPI0515482A (pt) derivados heterocìclicos e seus usos como agentes terapêuticos
NZ533310A (en) Benzimidazoles useful as protein kinase inhibitors
BRPI0515477A (pt) derivados heterocìclicos bicìclicos e o uso dos mesmos como inibidores de estaroil-coa-desaturase (scd)
BRPI0515489A (pt) derivados heterocìclicos e sua utilização como inibidores de estearoil-coa desaturase
DE602004022668D1 (de) 5-gliedrige heterocyclische p-38 inhibitoren
EA200701930A1 (ru) Производные пиримидина для лечения гиперпролиферативных нарушений
BRPI0515478A (pt) derivados heterocìclicos e seu uso como mediadores de estearoil-coa-desaturase
NO20075169L (no) Nye imidazo (1,5-A)pyndindenvater, fremgangsmate for fremstilling og farmasoytiske sammensetninger som inneholder samme.
MX2007000028A (es) Derivados de nicotinamida y su uso como agentes terapeuticos.
BRPI0409367A (pt) derivados de piperidina inibidores de renina
DE60321808D1 (de) Flavon derivate als inhibitoren von cyclin-abhängigen kinasen
EA200701114A1 (ru) Азоловые производные с антимускариновой активностью
DE602005010970D1 (de) Indol-derivate und ihre verwendung als kinase-hemmer, insbesondere ikk2-hemmer
MY139941A (en) Indole derivatives
CY1109569T1 (el) Υποκατεστημενα παραγωγα κυκλοεξανο-1,4-διαμινης

Legal Events

Date Code Title Description
FB Suspension of granting procedure